<DOC>
	<DOCNO>NCT03048240</DOCNO>
	<brief_summary>The study pilot evaluate feasibility `` 5-ALA- PpIX ( protoporhyrin IX ) mediate per-PDT protocol '' patient glioblastoma accessible complete surgical removal contrast . This treatment carry addition current reference treatment glioblastoma : maximum resection surgery follow radiochemotherapy accord protocol Stupp</brief_summary>
	<brief_title>INtraoperative photoDYnamic Therapy GliOblastoma</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>1 . Patient male female ≥18 year 2 . General status ( WHO ) Performance status 0 , 1 2 3 . Probable glioblastoma accord clinical radiological criterion , 4. whose surgical indication give Multidisciplinary consultation meeting ( RCP ) neurooncology , 5 . Decision treat patient part Clinical trial also take neurooncology RCP ( `` Multidisciplinary consultation meeting '' ) 6 . Patient operable basis absence cardiopulmonary disease history ; complete medical checkup sufficient insure postoperative state normal daily life 7 . Clinical neurooncological monitoring longterm MRI schedule hospital CHRU Lille , center reference region 8 . Patient able understand sign voluntarily Informed consent 9 . Patient able adhere visit 's calendar study imperatives protocol 10 . Women childbearing potential benefit effective contraception 11 . For patient receive hepatotoxic therapy long term , treatment must suspend 24h take 5ALA 12 . Patient assign heath insurance 1 . Contraindications 5ALA ( Gliolan® ) peroperative PhotoDynamic Therapy `` perPDT '' : 2 . Contraindications 5ALA Porphyria Taking photosensitizer treatment Severe renal hepatic impairment Bilirubin &gt; 1.5 x maximum level , Alkaline Phosphatases transaminase ( ASAT ) &gt; 2.5 x Maximum . rate Creatinine clearance &lt; 30 mL / min ; Noncompliance rule prevention transient risk cutaneous photosensitization 3 . Contraindications surgery 4 . Contraindications magnetic resonance imaging ( MRI ) 5 . Treatment experimental drug within 30 Days prior start study 6 . Clinical followup impossible perform psychological , familial , social geographical reason , 7 . Legal incapacity ( person deprive liberty Guardianship guardianship ) , 8 . Pregnant nursing woman 9 . Refusal participate sign consent study 10 . Soy allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Glioblastoma</keyword>
</DOC>